Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Research Methodology›Cochrane Risk of Bias Tool 2.0 for Randomized Controlled Trials
Process / pipelineRCT quality assessment

Cochrane Risk of Bias Tool 2.0 for Randomized Controlled Trials

Cochrane Risk of Bias Tool Version 2.0 · Also known as: RoB 2.0, RoB 2

RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 1 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Cochrane RoB 2.0
CASP RCT ChecklistCONSORT Reporting Checkl…GRADE Evidence ProfilingPRISMA ChecklistCOSMIN ChecklistMMATNewcastle-Ottawa Scale

When to use it

RoB 2 is mandatory in Cochrane systematic reviews of randomized trials. Use when appraising RCT quality for clinical guidelines, meta-analyses, or evidence synthesis. Essential when trials will inform clinical decision-making or policy recommendations.

Strengths & limitations

Strengths
  • Domain-based structure aligns with mechanisms of bias, making judgment more transparent and defensible
  • Signalling questions provide consistent guidance across reviewers and studies, improving inter-rater reliability
  • Updated judgment incorporates modern trial design practices (e.g., blinding of outcome assessors, adjustment for confounding)
  • Flexible approach accommodates diverse trial designs and contexts; guidance includes publication-specific algorithms
  • Explicitly addresses intention-to-treat analysis and missing data mechanisms, reflecting current evidence standards
Limitations
  • Requires detailed extraction of trial methods and analysis; assessments may be hampered by inadequate reporting in published papers
  • Signalling questions sometimes have ambiguous answers, necessitating reviewer judgment and potentially introducing subjectivity
  • Scoring algorithm does not generate a total 'bias score'; integration of five domain judgments is categorical, not quantitative, limiting ranking or weighting of trials
  • User training and familiarity with RoB 2 guidance is essential; complex algorithm requires consultation of domain-specific algorithms

Frequently asked

Does RoB 2 produce a numerical score?

No. RoB 2 uses categorical judgments (Low Risk, Some Concerns, High Risk) for each domain and overall. Some systematic review software tools display a visual summary (e.g., traffic-light chart) but no total score is calculated.

Can I use RoB 2 for observational studies or non-randomized trials?

No. RoB 2 is designed exclusively for randomized trials (RCTs and cluster-randomized trials). For observational studies, use Newcastle-Ottawa Scale or other tools; for non-randomized interventional studies, consult ROBINS-I.

How long does RoB 2 assessment take per trial?

Typically 30–90 minutes per trial, depending on report quality, complexity, and reviewer familiarity. Detailed trial reports with protocols available reduce time; sparse reports increase time due to contacting authors or marking as unclear.

What is the difference between 'Some Concerns' and 'High Risk' in a domain?

'Some Concerns' indicates that bias cannot be ruled out but there is insufficient evidence of likely bias; 'High Risk' means there is substantial evidence (e.g., lack of blinding without objective outcomes) that bias probably did occur and may have affected results.

Should I exclude High Risk trials from my meta-analysis?

Not automatically. The effect of bias on a particular outcome must be evaluated. Instead, conduct a main analysis and a sensitivity analysis excluding High Risk trials; report both. Direction and magnitude of potential bias inform interpretation.

Sources

  1. Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. DOI: 10.1136/bmj.l4898 ↗

How to cite this page

ScholarGate. (2026, June 3). Cochrane Risk of Bias Tool Version 2.0. ScholarGate. https://scholargate.app/en/research-methodology/cochrane-risk-of-bias

Related methods

CASP RCT ChecklistCONSORT Reporting ChecklistGRADE Evidence ProfilingPRISMA Checklist

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • CASP RCT ChecklistResearch Methodology↔ compare
  • CONSORT Reporting ChecklistResearch Methodology↔ compare
  • GRADE Evidence ProfilingResearch Methodology↔ compare
  • PRISMA ChecklistResearch Methodology↔ compare
Compare side by side →

Referenced by

CASP RCT ChecklistCONSORT Reporting ChecklistCOSMIN ChecklistGRADE Evidence ProfilingMMATNewcastle-Ottawa ScalePRISMA Checklist

Similar methods

CASP RCT ChecklistJBI Critical Appraisal ToolsMMATCONSORT Reporting ChecklistGRADE Evidence ProfilingNewcastle-Ottawa ScalePRISMA ChecklistSystematic Review

Related reference concepts

Risk of Bias AssessmentCritical Appraisal Tools and ChecklistsCONSORT Statement and RCT ReportingEvidence Evaluation and Critical AppraisalCertainty of Evidence RatingEvidence Hierarchies and Quality Appraisal

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Cochrane RoB 2.0 (Cochrane Risk of Bias Tool Version 2.0). Retrieved 2026-07-21 from https://scholargate.app/en/research-methodology/cochrane-risk-of-bias · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Jonathan Sterne, Julian Higgins (Cochrane Collaboration)
Subfamily
RCT quality assessment
Year
2019
Type
Clinician-rated / Research team assessment
Related methods
CASP RCT ChecklistCONSORT Reporting ChecklistGRADE Evidence ProfilingPRISMA Checklist
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account